GLP1R and medullary thyroid gland carcinoma: However, since there is still controversy regarding the possibility of GLP-1 agonists increasing risk of some malignancies in humans, including MTC, a personal or family history of MTC or MEN2 are contraindications for GLP-1 based therapy.